Company / Shareholders' Equity
Solid Biosciences Inc. Shareholders' Equity History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$208.2M
FY2022
5-year range
-$59.3M / $208.2M
FY2018-FY2022
Trend
+57.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $80M to $208M over the past 2 years.
Based on SEC 10-K filings.
$208M in FY2022 with a 3-year CAGR of +18.5%.
Improved from $80M to $208M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +18.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +18.5%, indicating consistent growth.
- In FY2022, shareholders' equity increased 57.6% year-over-year.
- Lowest shareholders' equity in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $208.2M | +57.6% |
| FY2021 | $132.1M | +65.0% |
| FY2020 | $80.0M | -36.1% |
| FY2019 | $125.2M | +311.3% |
| FY2018 | -$59.3M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026